BACKGROUND. Recent studies suggest that doses of epinephrine of 0.1 mg per kilogram of body weight or higher may improve myocardial and cerebral blood flow as well as survival in cardiac arrest. Such studies have called into question the traditional dose of epinephrine (0.007 to 0.014 mg per kilogram) recommended for advanced cardiac life support. METHODS. We randomly assigned 650 patients who had had cardiac arrest either in or outside the hospital to receive up to five doses of high-dose (7 mg) or standard-dose (1 mg) epinephrine at five-minute intervals according to standard protocols for advanced cardiac life support. Patients who collapsed outside the hospital received no advanced-life-support measures other than defibrillation before reaching the hospital. RESULTS. There was no significant difference between the high-dose group (n = 317) and the standard-dose group (n = 333) in the proportions of patients who survived for one hour (18 percent vs. 23 percent, respectively) or who survived until hospital discharge (3 percent vs. 5 percent). Among the survivors, there was no significant difference in the proportions who remained in the best category of cerebral performance (90 percent vs. 94 percent) and no significant difference in the median Mini-Mental State score (36 vs. 37). The exploration of clinically important subgroups, including those with out-of-hospital arrest (n = 335) and those with in-hospital arrest (n = 315), failed to identify any patients who appeared to benefit from high-dose epinephrine and suggested that some patients may have worse outcomes after high-dose epinephrine. CONCLUSION. High-dose epinephrine was not found to improve survival or neurologic outcomes in adult victims of cardiac arrest.
Source Information
Division of Emergency Medicine, University of Ottawa, Ont., Canada.
This article has been cited by other articles:
Ibrahim, W. H
(2007). Recent advances and controversies in adult cardiopulmonary resuscitation. Postgrad. Med. J.
83: 649-654
[Abstract][Full Text]
Varon, J., Marik, P. E.
(2007). Cardiopulmonary Resuscitation in Patients With Cancer. AM J HOSP PALLIAT CARE
24: 224-229
[Abstract]
Fang, X., Tang, W., Sun, S., Huang, L., Chang, Y.-T., Huang, Z., Weil, M. H.
(2006). Cardiopulmonary resuscitation in a rat model of chronic myocardial ischemia. J. Appl. Physiol.
101: 1091-1096
[Abstract][Full Text]
(2005). Part 7.2: Management of Cardiac Arrest. Circulation
112: IV-58-IV-66
[Full Text]
Koshman, S. L, Zed, P. J, Abu-Laban, R. B
(2005). Vasopressin in Cardiac Arrest. The Annals of Pharmacotherapy
39: 1687-1692
[Abstract][Full Text]
Sun, S., Weil, M. H., Tang, W., Kamohara, T., Klouche, K.
(2004). {delta}-Opioid receptor agonist reduces severity of postresuscitation myocardial dysfunction. Am. J. Physiol. Heart Circ. Physiol.
287: H969-H974
[Abstract][Full Text]
Perondi, M. B. M., Reis, A. G., Paiva, E. F., Nadkarni, V. M., Berg, R. A.
(2004). A Comparison of High-Dose and Standard-Dose Epinephrine in Children with Cardiac Arrest. NEJM
350: 1722-1730
[Abstract][Full Text]
Pellis, T., Weil, M. H., Tang, W., Sun, S., Xie, J., Song, L., Checchia, P.
(2003). Evidence Favoring the Use of an {alpha}2-Selective Vasopressor Agent for Cardiopulmonary Resuscitation. Circulation
108: 2716-2721
[Abstract][Full Text]
Cao, L., Weil, M. H., Sun, S., Tang, W.
(2003). Vasopressor Agents for Cardiopulmonary Resuscitation. J CARDIOVASC PHARMACOL THER
8: 115-121
[Abstract]
KAMOHARA, T., WEIL, M. H., TANG, W., SUN, S., YAMAGUCHI, H., KLOUCHE, K., BISERA, J.
(2001). A Comparison of Myocardial Function after Primary Cardiac and Primary Asphyxial Cardiac Arrest. Am. J. Respir. Crit. Care Med.
164: 1221-1224
[Abstract][Full Text]
Tang, W., Weil, M. H., Sun, S., Povoas, H. P., Klouche, K., Kamohara, T., Bisera, J.
(2001). A Comparison of Biphasic and Monophasic Waveform Defibrillation After Prolonged Ventricular Fibrillation. Chest
120: 948-954
[Abstract][Full Text]
Wenzel, V., Lindner, K. H.
(2001). Employing vasopressin during cardiopulmonary resuscitation and vasodilatory shock as a lifesaving vasopressor. Cardiovasc Res
51: 529-541
[Abstract][Full Text]
van Walraven, C., Forster, A. J., Parish, D. C., Dane, F. C., Chandra, K. M. D., Durham, M. D., Whaley, C., Stiell, I.
(2001). Validation of a Clinical Decision Aid to Discontinue In-Hospital Cardiac Arrest Resuscitations. JAMA
285: 1602-1606
[Abstract][Full Text]
DiGregorio, R. V.
(2001). Pharmacotherapeutic Advances in Cardiac Resuscitation: A Review of the Advanced Cardiac Life Support (ACLS) 2000 Guidelines and Their Impact on Pharmacy Practice. Journal of Pharmacy Practice
14: 41-53
[Abstract]
Niermeyer, S., Carlo, W., Boyle, D., Goldsmith, J., Nightengale, B., Perlman, J., Solimano, A., Speer, M., Wiswell, T.
(2001). What Is on the Horizon for Neonatal Resuscitation?. NeoReviews
2: e51-57
[Full Text]
Tang, W., Weil, M. H., Sun, S., Pernat, A., Mason, E.
(2000). KATP channel activation reduces the severity of postresuscitation myocardial dysfunction. Am. J. Physiol. Heart Circ. Physiol.
279: H1609-H1615
[Abstract][Full Text]
Ewy, G. A., Ornato, J. P.
(2000). Emergency cardiac care: introduction. J Am Coll Cardiol
35: 825-880
[Full Text]
Wenzel, V., Lindner, K. H., Krismer, A. C., Voelckel, W. G., Schocke, M. F., Hund, W., Witkiewicz, M., Miller, E. A., Klima, G.u., Wissel, J.o., Lingnau, W., Aichner, F. T.
(2000). Survival with full neurologic recovery and no cerebral pathology after prolonged cardiopulmonary resuscitation with vasopressin in pigs. J Am Coll Cardiol
35: 527-533
[Abstract][Full Text]
Ballew, K. A., Philbrick, J. T., Kudenchuk, P. J., Cobb, L. A., Copass, M. K.
(2000). Amiodarone in Out-of-Hospital Cardiac Arrest. NEJM
342: 216-217
[Full Text]
Sun, S., Weil, M. H., Tang, W., Povoas, H. P., Mason, E.
(1999). Combined Effects of Buffer and Adrenergic Agents on Postresuscitation Myocardial Function. J. Pharmacol. Exp. Ther.
291: 773-777
[Abstract][Full Text]
Tang, W., Weil, M. H., Sun, S., Yamaguchi, H., Povoas, H. P., Pernat, A. M., Bisera, J.
(1999). The effects of biphasic and conventional monophasic defibrillation on postresuscitation myocardial function. J Am Coll Cardiol
34: 815-822
[Abstract][Full Text]
Bakker, J., Rommes, H., Martens, P. R., Gueugniaud, P.-Y., Mols, P., Pannetier, J.-C.
(1999). Epinephrine for Out-of-Hospital Cardiac Arrest. NEJM
340: 1763-1765
[Full Text]
Wenzel, V., Lindner, K. H., Krismer, A. C., Miller, E. A., Voelckel, W. G., Lingnau, W.
(1999). Repeated Administration of Vasopressin but Not Epinephrine Maintains Coronary Perfusion Pressure After Early and Late Administration During Prolonged Cardiopulmonary Resuscitation in Pigs. Circulation
99: 1379-1384
[Abstract][Full Text]
Sanders, A. B.
(1999). Do We Need a Clinical Decision Rule for the Discontinuation of Cardiac Arrest Resuscitations?. Arch Intern Med
159: 119-121
[Full Text]
van Walraven, C., Forster, A. J., Stiell, I. G.
(1999). Derivation of a Clinical Decision Rule for the Discontinuation of In-Hospital Cardiac Arrest Resuscitations. Arch Intern Med
159: 129-134
[Abstract][Full Text]
Gueugniaud, P.-Y., Mols, P., Goldstein, P., Pham, E., Dubien, P.-Y., Deweerdt, C., Vergnion, M., Petit, P., Carli, P., The European Epinephrine Study Group,
(1998). A Comparison of Repeated High Doses and Repeated Standard Doses of Epinephrine for Cardiac Arrest Outside the Hospital. NEJM
339: 1595-1601
[Abstract][Full Text]
Adgey, A A J, Johnston, P W
(1998). Approaches to modern management of cardiac arrest. Heart
80: 397-401
[Full Text]
Adgey, A A J
(1998). Adrenaline dosage and buffers in cardiac arrest. Heart
80: 412-414
[Full Text]
Advanced Life Support Working Group of the Europea,
(1998). The 1998 European Resuscitation Council guidelines for adult advanced life support. BMJ
316: 1863-1869
[Full Text]
Nichol, G., Hallstrom, A. P., Ornato, J. P., Riegel, B., Stiell, I. G., Valenzuela, T., Wells, G. A., White, R. D., Weisfeldt, M. L.
(1998). Potential Cost-effectiveness of Public Access Defibrillation in the United States. Circulation
97: 1315-1320
[Abstract][Full Text]
Xie, J., Weil, M. H., Sun, S., Tang, W., Sato, Y., Jin, X., Bisera, J.
(1997). High-Energy Defibrillation Increases the Severity of Postresuscitation Myocardial Dysfunction. Circulation
96: 683-688
[Abstract][Full Text]
Nadkarni, V., Hazinski, M. F., Zideman, D., Kattwinkel, J., Quan, L., Bingham, R., Zaritsky, A., Bland, J., Kramer, E., Tiballs, J.
(1997). Pediatric Resuscitation : An Advisory Statement From the Pediatric Working Group of the International Liaison Committee on Resuscitation. Circulation
95: 2185-2195
[Full Text]
Carpenter, T. C., Stenmark, K. R.
(1997). High-dose Epinephrine Is Not Superior to Standard-dose Epinephrine in Pediatric In-hospital Cardiopulmonary Arrest. Pediatrics
99: 403-408
[Abstract][Full Text]
Idris, A. H., Becker, L. B., Ornato, J. P., Hedges, J. R., Bircher, N. G., Chandra, N. C., Cummins, R. O., Dick, W., Ebmeyer, U., Halperin, H. R., Hazinski, M. F., Kerber, R. E., Kern, K. B., Safar, P., Steen, P. A., Swindle, M. M., Tsitlik, J. E., von Planta, I., von Planta, M., Wears, R. L., Weil, M. H.
(1996). Utstein-Style Guidelines for Uniform Reporting of Laboratory CPR Research: A Statement for Healthcare Professionals From a Task Force of the American Heart Association, the American College of Emergency Physicians, the American College of Cardiology, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, the Institute of Critical Care Medicine, the Safar Center for Resuscitation Research, and the Society for Academic Emergency Medicine. Circulation
94: 2324-2336
[Full Text]
Mattana, J., Singhal, P. C., Kalsner, S., Brown, C. G., Martin, D. R., Pepe, P. E.
(1993). High-Dose Epinephrine in Cardiopulmonary Resuscitation. NEJM
328: 735-736
[Full Text]